Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 21 tags : Treatment save search
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) plus Yervoy (ipilimumab) for Treatment of Mismatch Repair Deficient
Published: 2021-05-21 (Crawled : 23:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
treatment positive chmp nivolumab
RYBREVANT™ (amivantamab-vmjw) Receives FDA Approval as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Published: 2021-05-21 (Crawled : 19:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
treatment fda lung cancer fda approval cancer approval
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR DeficiencyEuropean Commission decision anticipated in July
Published: 2021-05-21 (Crawled : 17:00) - biospace.com/
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 1.17%
H: 3.83%
C: -0.28%
treatment obesity europe positive setmelanotide chmp
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or ScalpEuropean Commission Decision Anticipated by July 2021
Published: 2021-05-21 (Crawled : 16:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 1.04%
H: 1.85%
C: -1.85%
treatment actinic keratosis europe positive tirbanibulin chmp ema
Almirall receives positive CHMP opinion for Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis
Published: 2021-05-21 (Crawled : 14:00) - prnewswire.com
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 1.04%
H: 1.85%
C: -1.85%
treatment actinic keratosis positive tirbanibulin chmp
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp
Published: 2021-05-21 (Crawled : 14:00) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 1.04%
H: 1.85%
C: -1.85%
treatment actinic keratosis europe positive tirbanibulin chmp ema
CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 14:00) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.21%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.75%
H: 0.13%
C: -1.44%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
covid treatment positive biotech technology iot ema
Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Women With Uterine Fibroids
Published: 2021-05-21 (Crawled : 13:00) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 1.71%
H: 4.69%
C: 1.59%
treatment positive women chmp
Soleno Therapeutics to Host Webinar Highlighting DCCR for Treatment of Prader-Willi Syndrome at European Congress on Endocrinology 2021European Key Opinion Leaders to Participate in Event
Published: 2021-05-21 (Crawled : 13:00) - biospace.com/
SLNO | News | $37.53 1.02% 1.01% 190K
|
Health Technology
|
| O: 1.98%
H: 1.94%
C: 0.0%
treatment europe syndros
Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
Published: 2021-05-21 (Crawled : 13:00) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 7.57%
H: 0.0%
C: -2.16%
treatment positive chmp
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
Published: 2021-05-21 (Crawled : 13:00) - globenewswire.com
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 1.17%
H: 3.83%
C: -0.28%
treatment obesity positive setmelanotide chmp
Soleno Therapeutics to Host Webinar Highlighting DCCR for Treatment of Prader-Willi Syndrome at European Congress on Endocrinology 2021
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
SLNO | News | $37.53 1.02% 1.01% 190K
|
Health Technology
|
| O: 1.98%
H: 1.94%
C: 0.0%
treatment europe syndros
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
Published: 2021-05-21 (Crawled : 12:15) - globenewswire.com
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.26%
C: -0.21%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 1.75%
H: 0.13%
C: -1.44%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
covid treatment positive biotech technology iot ema
BeiGene Announces Positive Topline Results from Phase 3 Trial of Tislelizumab in Combination with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Published: 2021-05-21 (Crawled : 12:00) - biospace.com/
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
treatment positive therapy results cancer topline phase 3 trial
U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment
Published: 2021-05-21 (Crawled : 10:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.75%
H: 0.63%
C: -0.17%
food treatment drug injection infections
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770
|
Finance
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
MGLD 4 | $1.23 8.85% 7.32% 14K
|
Manufacturing
GRFX | $0.2116 -1.58% 7.28% 40K
|
n/a
LYT | $4.22 4.72% 5.62% 1.4M
|
SYY | $76.73 1.44% 5.49% 2.5M
|
Distribution Services
TWI | $11.53 0.96% 4.94% 330K
|
Producer Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.